232 related articles for article (PubMed ID: 28118809)
1. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
[TBL] [Abstract][Full Text] [Related]
2. Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.
Sachar M; Li F; Liu K; Wang P; Lu J; Ma X
Chem Res Toxicol; 2016 Aug; 29(8):1293-7. PubMed ID: 27438535
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice.
Dong Y; Huang J; Lin X; Zhang S; Jiao Y; Liang T; Chen Z; Huang R
J Ethnopharmacol; 2014 Feb; 152(1):201-6. PubMed ID: 24412379
[TBL] [Abstract][Full Text] [Related]
5. The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
Brewer CT; Yang L; Edwards A; Lu Y; Low J; Wu J; Lee RE; Chen T
Toxicol Sci; 2019 Mar; 168(1):209-224. PubMed ID: 30517741
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.
Lian Y; Zhao J; Xu P; Wang Y; Zhao J; Jia L; Fu Z; Jing L; Liu G; Peng S
PLoS One; 2013; 8(8):e72058. PubMed ID: 23967274
[TBL] [Abstract][Full Text] [Related]
7. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of the bioactive natural product N-trans-Caffeoyldopamine on hepatotoxicity induced by isoniazid and rifampicin.
Wu ZR; Bai ZT; Sun Y; Chen P; Yang ZG; Zhi DJ; Li Y; Wang X; Du JJ; Yang R; Cui P; Zhang Y; Li HY
Bioorg Med Chem Lett; 2015 Nov; 25(22):5424-6. PubMed ID: 26410075
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review.
Zhuang X; Li L; Liu T; Zhang R; Yang P; Wang X; Dai L
Front Pharmacol; 2022; 13():1037814. PubMed ID: 36299895
[TBL] [Abstract][Full Text] [Related]
11. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
12. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
[TBL] [Abstract][Full Text] [Related]
13. Induction of Heme oxygenase 1 protects hepatocytes from Isoniazid – Rifampicin induced cell death: an in vitro study.
Bishnu D; Santra S; Dhali GK; Chowdhury A; Santra A
Trop Gastroenterol; 2016; 37(1):27-36. PubMed ID: 29668174
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
15. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
[TBL] [Abstract][Full Text] [Related]
16. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
17. The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
Baskaran UL; Sabina EP
Cell Biol Toxicol; 2015 Oct; 31(4-5):211-9. PubMed ID: 26374116
[TBL] [Abstract][Full Text] [Related]
18. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
Wang C; Fan RQ; Zhang YX; Nie H; Li K
World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
Yue J; Peng RX; Yang J; Kong R; Liu J
Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Study to Determine the Mechanism Underlying the Effects of
Ke XH; Wang CG; Luo WZ; Wang J; Li B; Lv JP; Dong RJ; Ge DY; Han Y; Yang YJ; Tu-Erxun RY; Liu HS; Wang YC; Liao Y
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
